All News

Foreign player? Choose a local partner

Know your strengths, then expand

Russia had been a country in flux-monetary crises, corruption scandals, oil surpluses, etc. But no multinational should be scared off by the market anymore, not with its economy on the verge of breaking out.

The triple bottom line

A celebration of achievement

If high prices that lower access are attributable to a flawed R&D model, can industry embrace delivering better results at lower costs.

Pharm Exec's 2011 Emerging Leaders celebration convened Oct. 6 in New York.

Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?

Invitation Application for Pharma and Biotech Industry Executives:

Thirty Years of Pharm Exec

Atsushi Nagahisa, President & CEO, RaQualia

Jean-Claude Labrune, Chairman & CEO, Cegedim Group

Harvey Bale, Jr., MD, former Director-General, IFPMA

Robert Seidman, Former Chief Pharmacy Officer, Wellpoint

Jane Henney, MD, Former FDA Commissioner

P. Roy Vagelos, MD, Chairman Emeritus, Merck

Francis Collins, MD, PhD, Director, National Institutes of Health

Napoleone Ferrara, MD, PhD, Research Fellow, Genentech

Martin Wygod, Chairman, WebMD

Sidney Wolfe, MD, Director, Public Citizen's Health Research Group

Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine

Sir Martin Sorrell, CEO, WPP

Fernand Sauer, First Director General, European Medicines Agency

Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.

Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.

Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation

Three Decades of Politics and Pop Culture ... on Drugs

From Many, One